miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

MicroRNAs are key regulators of gene expression in tumorigenesis. In this study, we investigated the tumor-suppressive function of miR-31-3p. Analysis of the Gene Expression Omnibus database revealed that the expression of miR-31-3p in prostate cancer tissues is lower than that in adjacent normal tissues from patients with prostate cancer. Moreover, miR-31-3p induces apoptosis in DU145, PC-3, and LNCap prostate cancer cells, while those transfected with miR-31-3p exhibit significantly decreased cell proliferation, migration, invasiveness, and tumor sphere-forming ability, as determined using the cell counting kit-8, transwell, and sphere-forming assays. Further analysis revealed that GABBR2 is a direct target of miR-31-3p. Within a DU145 xenograft murine model, intratumoral injection of a miR-31-3p mimic suppresses tumor growth. Taken together, the findings of this study suggest that miR-31-3p performs a novel tumor-suppressive function in prostate cancer and may represent a novel target for anti-prostate cancer miRNA therapeutics.

Cite

CITATION STYLE

APA

Choi, S., Lee, S., Han, Y. H., Choi, J., Kim, I., Lee, J., & An, H. J. (2022). miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer. Frontiers in Oncology, 12. https://doi.org/10.3389/fonc.2022.945057

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free